Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment

Positive Mobilization Margins Alone Do Not Influence Survival Following Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma

(2010) Nigel B. Jamieson et al.   ANNALS OF SURGERY

Defining Venous Involvement in Borderline Resectable Pancreatic Cancer

(2010) Yun Shin Chun et al.   ANNALS OF SURGICAL ONCOLOGY

MDCT findings of extrapancreatic nerve plexus invasion by pancreas head carcinoma: correlation with en bloc pathological specimens and diagnostic accuracy

(2010) Kentaro Mochizuki et al.   EUROPEAN RADIOLOGY

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

(2010) Jerome Landry et al.   JOURNAL OF SURGICAL ONCOLOGY

Survival After Pancreaticoduodenectomy is not Improved by Extending Resections to Achieve Negative Margins

(2009) Jonathan Hernandez et al.   ANNALS OF SURGERY

AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and Overview of the Conference

(2009) Jean-Nicolas Vauthey et al.   ANNALS OF SURGICAL ONCOLOGY

Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

(2009) Ross A. Abrams et al.   ANNALS OF SURGICAL ONCOLOGY

Surgical Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

(2009) Douglas B. Evans et al.   ANNALS OF SURGICAL ONCOLOGY

Margin Clearance and Outcome in Resected Pancreatic Cancer

(2009) David K. Chang et al.   JOURNAL OF CLINICAL ONCOLOGY